Anti-Human IFNG Recombinant Antibody(Fontolizumab)

Product Information

Catalog Number	YR1022
Product Name	Anti-Human IFNG Recombinant Antibody(Fontolizumab)
Molecular Name	Fontolizumab
Alias	Anti-IFNG Recombinant Antibody, Research Grade Fontolizumab
CAS Number	326859-36-3
Target	IFNG[Homo sapiens]
Isotype	IgG1
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	IF, IP, Neut, FuncS, ELISA, FCM, ICC, Activ, WB
Buffer	PBS, pH7.5
Background	Fontolizumab (planned trade name HuZAF) is a humanized monoclonal antibody and an immunosuppressive drug for the treatment of auto-immune diseases like Crohn's disease. A phase II clinical trial investigating the use for rheumatoid arthritis was terminated because the first phase did not meet the endpoint.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price